CCR7 and rheumatoid arthritis: In psoriasis or rheumatoid arthritis, respectively, anti-TNF or FTY720 therapy downregulated CCR7 on DCs and then reduced DC aggregation in the lesional skin or dLNs, although the precise mechanism was still obfuscated (Bose et al., 2013; Han et al., 2015).